Phase IV study of efficacy and safety of enteric-coated mycophenolate sodium (EC-MPS) in combination with cyclosporine microemulsion (CsA-ME) in kidney transplant patients
Phase of Trial: Phase IV
Latest Information Update: 28 Feb 2017
At a glance
- Drugs Ciclosporin; Mycophenolate sodium
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Acronyms MYFORMS
- Sponsors Novartis
- 03 Nov 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Nov 2009 Actual end date (1 Aug 2006) added as reported by ClinicalTrials.gov.
- 17 Dec 2005 New trial record.